GTBP GT Biopharma Inc
Company Analysis
Latest News
🟢 GT Biopharma is trading 8% up in after-hours trading — catalyst unconfirmed
GT Biopharma is trading 7.74% up at $6.68 in after-hours on October 1, 2026; the reason for the gain remains unconfirmed. - The regular-session close was...
🔴 GT Biopharma is trading 6% down — cause remains unconfirmed
GT Biopharma is trading 6.03% down at $6.08 on October 1, 2026; the cause of the decline remains unconfirmed. - No clear company-specific announcement...
GT Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GT Biopharma, Inc. (GTBP) announced it has regained compliance with The Nasdaq Stock Market's minimum bid price requirement of $1.00 per share, resolving a...
🔴 GT Biopharma is trading 7.2% down today amid biotech-sector weakness
GT Biopharma is trading at $6.59, down 7.18%, with the decline most consistent with biotech-sector weakness and broader risk-off pressure. - No new...
🔴 GT Biopharma is trading 10.79% down today
GT Biopharma is trading 10.79% down at $6.41 after opening-session selling on September 22, 2026. - No new company-specific announcement dated September 22...
🔴 GT Biopharma is trading 5.99% down today
GT Biopharma is trading 5.99% down at $6.75 after opening-session selling on September 22, 2026. - No new company-specific announcement dated September 22 was...
🟢 GT Biopharma is trading 8.24% up today amid broad risk-on market gains
GT Biopharma is trading at $7.75, up 8.24%, as U.S. markets opened higher on September 21, 2026, supporting broader risk appetite. - The S&P 500, Nasdaq...
🟢 GT Biopharma is trading 5.17% up in pre-market after broader U.S. markets opened higher
GT Biopharma is trading 5.17% up at $7.53 after broader U.S. equity markets opened higher in pre-market trading. - The S&P 500, Nasdaq Composite, and Dow...
🔴 GT Biopharma is trading 5% down today after dilution concerns from $7.45 million private placement
GT Biopharma is trading at $7.11 (-5.07%) after continued selling followed its September 15, 2026 announcement of a $7.45 million private placement involving...
🔴 GT Biopharma is trading 18.95% down today after $7.45 million private placement raises dilution concerns
GT Biopharma is trading 18.95% down at $6.58 as investors continue selling over dilution concerns tied to the September 15 announcement of a $7.45 million...
🔴 GT Biopharma is trading 5.25% down in pre-market after $7.45 million private placement raised dilution concerns
GT Biopharma is trading 5.25% down at $7.40 in pre-market as investors continue reacting to its September 15 announcement of a $7.45 million private placement...
GT Biopharma's $7.45 Million Lifeline Sends Shares Into Free Fall — Can the Biotech Survive Without Drowning Existing Investors?
Shares of GT Biopharma cratered for a second straight session, trading at $7.99 — down 11.2% — as investors continued to punish the micro-cap biotech for a...
🔴 GT Biopharma is trading 11.2% down today after $7.45 million convertible financing raises dilution concerns
GT Biopharma is trading 11.2% down now at $7.99 as investors continue digesting its September 14, 2026, private placement of $7.45 million in securities,...
🔴 GT Biopharma is trading 6.1% down today after convertible financing raises dilution concerns
GT Biopharma is trading 6.1% down at $8.45 after investors digested its $7.45 million private placement of convertible preferred stock and warrants. -...
GT Biopharma Enters Agreement for $7.45 Million Private Placement Financing
GT Biopharma, Inc. has entered into a Securities Purchase Agreement for a private placement of convertible preferred stock and warrants, raising an aggregate...
🔴 GT Biopharma is trading 19% down today after a highly volatile speculative run
GT Biopharma is trading 19% down at $9.46 after a highly volatile speculative run. - It previously gained 35.08% on September 14 and 39.32% on September 11. -...
🟢 GT Biopharma is trading 13.82% up today amid speculative momentum and no confirmed catalyst
GT Biopharma is trading 13.82% up at $9.80, extending speculative momentum after rising 39.32% to $8.61 on September 11; no new September 14 company...
🟢 GT Biopharma is trading 6.16% up today; catalyst remains unconfirmed
GT Biopharma is trading 6.16% up at $8.94, with today’s specific catalyst unconfirmed. - Shares rose 39.32% on September 11, following the 1-for-25 reverse...
🟢 GT Biopharma is trading 10% up today after August CPI matched expectations
GT Biopharma is trading at $6.80, up 10.01% after August CPI matched expectations and supported broader risk-on sentiment. - Major indexes are higher: S&P 500...
🟢 GT Biopharma is trading 6.5% up in pre-market after August CPI matched expectations
GT Biopharma is trading $6.58 (+6.50%) as broader risk-on sentiment followed August CPI data that matched expectations. • Major indexes are higher, with the...